Evidence map›Paper›PMID 36338201›Full record

ReviewWorld journal of clinical cases2022

Ketosis-prone diabetes mellitus: A phenotype that hospitalists need to understand.

Sydney Boike, Mikael Mir, Ibtisam Rauf, Abbas B Jama, Shaleen Sunesara, Hisham Mushtaq, Anwar Khedr, Jain Nitesh, Salim Surani, Syed A Khan

Open access · diamondAbstract readReview
In one paragraph

Review in World journal of clinical cases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. MODY Only Monogenic? A Narrative Review of theInternational journal of molecular sciences · 2024
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Sydney BoikeMedicine, University of Minnesota Medical School, Minneapolis, MN 55455, United States.
Mikael MirMedicine, University of Minnesota Medical School, Minneapolis, MN 55455, United States.
Ibtisam RaufMedicine, St. George's School of Medicine, Grenada FZ818, West Indies.
Abbas B JamaCritical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.
Shaleen SunesaraMedicine, University of Southern California, Los Angeles, CA 90007, United States.
Hisham MushtaqMedicine, St. Vincent's Medical Center, Bridgeport, CT 06606, United States.
Anwar KhedrMedicine, BronxCare Health System, Bronx, NY 10457, United States.
Jain NiteshCritical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.
Salim SuraniMedicine, Texas A&M University, Bryan, TX 77843, United States.
Syed A KhanCritical Care Medicine, Mayo Clinic Health System, Mankato, MN 56001, United States.
Mayo Clinic Health System · USUniversity of Minnesota Medical Center · USMayo Clinic · USMontefiore Health System · USSt. George's University · GDSt. Vincent's Medical Center · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes has been classified mainly into types 1 and 2. Some type 2 diabetes patients, when developing ketosis, have been labeled as having atypical diabetes. Lately, syndromes of ketosis-prone diabetes, primarily in patients who we previously classified as type 2 diabetics, have emerged, and calls are being made to even reclassify diabetes. This mini-review will extensively deal with the historical, molecular, phenotypical, and clinical basis of why ketosis-prone diabetes is different than the traditional principles of type 1 and 2 diabetes and should be classified as such. Clinicians, especially those who are not diabetologists or endocrinologists, as well as hospitalists, intensivists, and primary care providers, will greatly benefit from this review.

Indexed as

AcidosisDiabetesDiabetes prone ketosisDiabetic ketoacidosisKetosis

Identifiers

PMID36338201
PMCPMC9631166
OpenAlexW4306783369

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.